ClinicalTrials.gg
CompletedNCT00472485Updated Jul 3, 2008

Study of Eye Movement Testing and Therapy

An interventional study of eye movement therapy in Saccadic Eye Movement Deficiency, Oculomotor Deficiency and Oculomotor Dysfunction, sponsored by Ohio State University. Completed at 1 site in United States. Open to participants aged 8 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-07-03.

Sponsored by Ohio State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
8 Years to 13 Years
Sex
All
01

Study summary

The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.

02

Conditions studied

  • Saccadic Eye Movement Deficiency
  • Oculomotor Deficiency
  • Oculomotor Dysfunction
03

In context

Lead sponsor

Ohio State University is the lead sponsor of 661 studies on the registry; 148 are open to participants now.

Of its 66 completed or terminated interventional studies of FDA-regulated products, 49 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children ages 8 to 13 with saccadic eye movement deficit

Exclusion criteria

Exclusion Criteria:

  • Previous saccadic eye movement therapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants

Interventions

  • Procedureeye movement therapy
06

Study locations

1 site
  • The Ohio State University
    Columbus, Ohio 43210, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00472485
First posted
May 11, 2007
Last update
Jul 3, 2008

Study contacts

Marjean Kulp, OD, MS
principal investigator · Ohio State University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion